Pharmaceutical News and Articles

Teva wins approval for generic Tamoxifen Citrate Tablets

Teva wins approval for generic Tamoxifen Citrate Tablets

JERUSALEM, ISRAEL, Feb. 21, 2003 -- Teva Pharmaceutical Industries announced that the FDA  has approved the company's ANDAs for Tamoxifen Citrate Tablets USP, 10 mg and 20 mg. Shipments will begin immediately.

Tamoxifen Citrate Tablets are the AB-rated generic equivalent of AstraZeneca's Nolvadex Tablets, an anti-estrogen drug for the treatment of breast cancer.

Source: Teva Pharmaceutical Industries

Latest Pharma Industry News...

Pharma Industry News Archive

2009: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

MedNotes
Advertisement

(web4)